BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 22, 1997
View Archived Issues
Eisai: Annual Report 1997
Read More
LXR issued two U.S. patents for naturally occurring death receptor
Read More
AF-1 stimulates CNS regeneration in animal models; proof of principle established
Read More
ArQule and Acacia to develop novel drug candidates
Read More
CoCensys and Warner-Lambert renew and expand neurologic drug development collaboration
Read More
New estrogen receptor ligand reported by Glaxo Wellcome
Read More
Merck & Co.: Q3 1997 highlights
Read More
New nonimmunosuppressive CsA derivative with potent anti-Toxoplasma activity
Read More
Patents issued to Corvas for serine protease inhibitors
Read More
Romozin now available in U.K.
Read More
Zorac introduced in U.K. for psoriasis
Read More
Cephalon and Kyowa Hakko issued patents on neurotrophic small molecules
Read More
Aronex receives grants for development of HIV integrase inhibitor
Read More
Dopamine D1 agonists improve spatial working memory in aged monkeys
Read More
Identification of metabolites of Sch-48461 leads to potent cholesterol absorption inhibitor
Read More
FDA clears generic transdermal nicotine product
Read More
PathoGenesis initiates phase II trial with new antiinfective for tuberculosis
Read More
NeoPharm moves LED to phase I for prostate cancer
Read More
Mechanism of cytoprotective effects of bimoclomol
Read More
Procept completes phase I testing with PRO-2000 gel
Read More
OraVax to develop new treatments for Clostridium difficile-associated disease
Read More
Nymox's urinary test for Alzheimer's disease successfully completes initial trials
Read More
Zeneca introduces zolmitriptan in Germany
Read More
German launch for Roche's mibefradil
Read More
Endocrinologic and Metabolic Drugs Advisory Committee meets in late November
Read More
Axcan completes phase III trial for H. pylori eradication
Read More
FDA advisory committee to review finasteride for alopecia
Read More
